Description: SkinBioTherapeutics PLC is a life science company focused on skin health. The Company’s platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company’s SkinBiotix platform can improve the barrier effect of skin models, improve repair and reduce bacterial load. It focuses on three specific skin healthcare sectors: cosmetics, infection control and eczema. In each of these areas, the Company plans to exemplify its technology in human studies. The Company’s program is focused on the application of the Skinbiotix platform in managing sensitive skin in the cosmetics industry. SkinBiotix increases the rate of skin healing in response to injury.
Home Page: www.skinbiotherapeutics.com
SBTX Technical Analysis
The Core
Newcastle upon Tyne,
NE4 5TF
United Kingdom
Phone:
44 16 1468 2760
Officers
| Name | Title |
|---|---|
| Mr. Stuart John Ashman | CEO & Exec. Director |
| Mr. Douglas John Quinn | Company Sec. |
| Mr. Manprit Singh Randhawa | Chief Financial Officer |
| Dr. Catherine O'Neill | Chief Scientific Officer & Member of Scientific Advisory Board |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| GIC Sector: | Consumer Staples |
|---|---|
| GIC Group: | Household & Personal Products |
| GIC Industry: | Personal Products |
| GIC Sub-Industry: | Personal Products |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 6.7811 |
| Price-to-Sales TTM: | 1185.1074 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 12 |